Език: EN EN
← Назад към резултатите
Набира участници NCT06594913

Eating Disorders Genetics Initiative 2

Заболявания: Anorexia Nervosa Bulimia Nervosa Binge-Eating Disorder Avoidant Restrictive Food Intake Disorder

Спонсор: University of North Carolina, Chapel Hill

Налично на: БГ
Обобщение
The overarching intention of the Eating Disorder Genetics Initiative 2 (EDGI2) is to increase sample size, diversity, and eating disorder phenotypes. The investigators are enrolling 20,000 new participants with anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), avoidant/restrictive food intake disorder (ARFID), and controls in the US, Mexico, Australia, New Zealand, Sweden, and Denmark. A primary study goal is to enroll at least 30% of participants from underrepresented groups. Participants are asked to complete a series of questionnaires and submit a saliva sample for genotyping. The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed.
Кой може да участва
Inclusion Criteria: * A lifetime history of anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant restrictive food intake disorders or no history of any disordered eating behavior, based on DSM-5 criteria algorithms * Age 12-99 years, depending on country. (US enrollment age is 18-99) Exclusion Criteria: * History of subthreshold disordered eating behaviors.
Места на провеждане 5
Австралия (1)
QIMR Berghofer
Brisbane , Queensland
Mexico (1)
Comenzar de Nuevo
Monterrey
New Zealand (1)
University of Otago
Christchurch , Canterbury
Швеция (1)
Karolinska Institutet
Stockholm
Lisa Dinkler, PhD
САЩ (1)
University of North Carolina at Chapel Hill
Chapel Hill , North Carolina
Технически детайли
Статус
Набира участници
Вид изследване
OBSERVATIONAL
Пол
Мъже и жени
Минимална възраст
12 Years
Максимална възраст
99 Years
Здрави доброволци
Не
Начална дата
28.10.2024
Крайна дата
01.08.2027
Регистрационен номер
NCT06594913
Източник
anzctr
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.